# Cartesian Therapeutics, Inc. (RNAC)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RNAC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 78.0K | $ -39.18M | $ -22.16M | $ 11.86M | $ -148.12M |
| 2025 | $ 2.86M | $ -133.42M | $ -81.29M | $ 12.68M | $ -126.24M |
| 2024 | $ 40.90M | $ -81.38M | $ -34.44M | $ 13.98M | $ -6.80M |
| 2023 | $ 28.12M | $ -237.56M | $ -55.54M | $ 10.96M | $ -440.18M |
| 2022 | $ 123.75M | $ 39.52M | $ -36.68M | $ 37.93M | $ 93.83M |
| 2021 | $ 101.13M | $ -30.53M | $ -73.06M | $ 35.28M | $ 22.52M |
| 2020 | $ 21.14M | $ -87.74M | $ 43.40M | $ 35.35M | $ -18.01M |
| 2019 | $ 8.62M | $ -71.44M | $ -66.45M | $ 19.28M | $ 8.40M |
| 2018 | $ 1.19M | $ -86.29M | $ -79.30M | $ 21.39M | $ -5.42M |
| 2017 | $ 278.9K | $ -88.00M | $ -71.09M | $ 21.04M | $ 51.81M |
| 2016 | $ 11.12M | $ -49.82M | $ -27.89M | $ 12.04M | $ 54.96M |
| 2015 | $ 8.44M | $ -35.35M | $ -33.17M | $ 11.86M | $ -116.49M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.08 |
| Liabilities / Eq | -2.95 |
| Current Ratio | 7.65 |

## Other views

- [Metrics](https://sponda.capital/en/RNAC.md)
- [Charts](https://sponda.capital/en/RNAC/charts.md)
- [Compare](https://sponda.capital/en/RNAC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.